Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade GliomaJ. Clin. Oncol 2022 Nov 14;[EPub Ahead of Print], E Bouffet, B Geoerger, C Moertel, JA Whitlock, I Aerts, D Hargrave, L Osterloh, E Tan, J Choi, M Russo, E Fox
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.